here’s a summary of the provided list of references:
this is a list of resources related to Gaucher disease and the treatment Cerezyme (imiglucerase). The references include:
* Sanofi’s summary of a clinical study (RC-91-0110) related to Cerezyme.
* A clinical update on Cerezyme from Optum, detailing an expanded indication.
* Information about the International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry (ClinicalTrials.gov identifier: NCT00358943).
all resources were accessed around January 26, 2026, with the ICGG registry being updated on January 6, 2026. The links provided are to PDF documents and a ClinicalTrials.gov entry.